Pharmaceutical Business review

Watson receives FDA final approval for generic Wellbutrin

Bupropion hydrochloride extended-release is the generic equivalent to GlaxoSmithKline’s Wellbutrin XL tablets, which is indicated for the treatment of major depressive disorder. The company intends to launch the product immediately.

Exit mobile version